13 Cheapest Tirzepatide Providers (2026)

The cheapest tirzepatide right now, ranked

Price is almost never one number with these programs. Most split the bill into a medication charge and a separate membership or consultation fee, and several quote a soft first month that quietly climbs afterward. The ranking above reflects the real ongoing cost — the month you will actually pay all year — with every extra called out in the row rather than buried under it.

On the medication line, compounded still undercuts the brand. The gap just isn't the chasm it was a year ago, and the lowest sticker is attached to a product whose legal footing has shifted. That distinction matters more for tirzepatide than for almost any other weight medication right now, so it's worth holding in mind as you read the provider-by-provider breakdown below.

Tirzepatide cost by provider

Gala — lowest flat rate, if you'll commit

Gala is the cheapest tirzepatide we can verify, and the price doesn't move as you titrate: $179 a month on a yearly plan or $199 a month on a 3-month plan, every dose included, with the assessment, dose adjustments, messaging and shipping folded in. It is also one of the few GLP-1 platforms built around women in midlife — estradiol, progesterone and non-hormonal hot-flash options (from $69 a month) sit on the same account, so one clinician can weigh the GLP-1 alongside hormone therapy.

The reservations are real. Both plans are prepaid and the terms return nothing on cancellation, the dispensing pharmacy is never named, and the company carries a C- from the BBB with a steady run of billing complaints (set against a large, mostly positive Trustpilot base). Start with the 3-month plan rather than the year, and only once the cancellation terms are clear to you.

• Pros — lowest verified rate, flat at every dose; consult, dose adjustments and shipping included; hormone therapy on the same platform.
• Cons — prepaid 3- or 12-month plans with no refunds; pharmacy not named; BBB C- with billing complaints; young company (founded 2024).

Curex — best for the lowest honest all-in price

Curex earns the top spot for a simple reason: the number you see is close to the number you pay. Compounded tirzepatide starts at roughly $199 a month, and that one figure is meant to cover the online consult, the medication, free shipping, and follow-up dose adjustments — with no membership fee bolted on the side. For a market where the real bill routinely lands a hundred dollars above the headline, that transparency is the whole pitch.

The honest catch is the word "from." The $199 is starter-dose language, and Curex doesn't publish its maintenance ladder as plainly, so it's reasonable to expect a higher number once you titrate up. Ask for the full dose-by-dose price in writing before you enroll, and you remove the only real surprise here.

• Pros — lowest verified all-in price; no separate membership; shipping and follow-ups included; oral and injectable formats.
• Cons — "from" pricing means maintenance doses may cost more than the starter; the higher-dose ladder isn't posted publicly.

LevelsRx — video visits and coaching from $240

LevelsRx is a new program that bundles what most cheap platforms strip out: unlimited video visits with a clinician, 1:1 nutrition coaching, auto-refills and shipping, with compounded tirzepatide advertised from $240 a month and its partner pharmacies named in the terms. The word to watch is "from" — the actual plan tiers only appear once you start the intake, the discounted rate reportedly carries a three-month minimum, and with a handful of public reviews it has almost no independent track record yet. Treat $240 as the floor and read the commitment before you pay.

• Pros — video visits, nutrition coaching and shipping included with no membership fee; partner pharmacies named; brand-name Wegovy/Zepbound on the same platform.
• Cons — "starting at" pricing with tiers hidden until intake; 3-month minimum on the intro rate; brand-new with only a few public reviews; served states not published.

Joi — hormone-first platform, $249 after a $149 first month

Joi is the women's side of a hormone-first telehealth company that added compounded GLP-1s, not the other way round — bioidentical estradiol, progesterone and testosterone are its core product, so a woman in her forties can have weight and perimenopause handled by one clinician and one coach. Tirzepatide runs $149 for the first month and $249 a month after that, with unlimited health coaching and clinician messaging included and no membership fee. The catch is the contract: everything is billed quarterly ($747 per three-month supply) with a three-month minimum, and the terms say all products are non-refundable.

• Pros — HRT and GLP-1 under one clinician; coaching included; cheap first month; pharmacy partners named; Trustpilot 4.5/5 across ~1,400 reviews.
• Cons — quarterly billing with a 3-month minimum and no refunds; GLP-1 is a secondary line for a hormone company; some states priced differently.

TrimRx — price locked through titration, from $259

TrimRx's one real differentiator is a price that stays locked at your plan rate however high your dose climbs — a genuine saving against programs that add $100 or more as you titrate. The $259 a month headline is a prepaid multi-month rate; month to month, tirzepatide lists at about $449, so the flat price only pays off if you commit. Consults, supplies and shipping are included, and its compounding partner is a known 503A sterile pharmacy in Texas, though you learn the name from third parties rather than the site. The weak point is billing: TrimRx sits at 3.6/5 on Trustpilot with a third of reviews one-star, almost all about auto-renewals and slow refunds.

• Pros — price locked at every dose; consults, supplies and shipping bundled; 503A sterile compounder; approval in 24–48 hours with no video call.
• Cons — $259 requires prepaying 3–12 months, non-refundable once medication ships; ~$449 month-to-month; persistent billing complaints; thin coaching.

ReadyRx — flat at every dose, $275 quarterly or $315 monthly

ReadyRx charges one price at every dose and nothing on top: $315 a month on a monthly plan or $275 a month if you prepay a quarter, with the clinician review, messaging and cold-chain shipping included and $20 off the first month. It is the best-reviewed of the newer names here — 4.7/5 across roughly a thousand Trustpilot reviews — and it puts a written weight-loss guarantee in its terms. Two things to check first: the compounding pharmacy isn't named before you enroll, and the service is excluded in about nine states (California and North Carolina among them for tirzepatide), which you only learn at intake.

• Pros — flat price at every dose with no membership; a true month-to-month option; written weight-loss guarantee; strong review base.
• Cons — excluded in ~9 states; pharmacy not named; text-only care; cancel at least four business days before renewal.

Mochi Health — best for transparent, pay-as-you-go billing

Mochi is the clearest example of why you read the whole bill. Its medication price is a flat $199 a month for every tirzepatide dose, shipping included — genuinely low. The part the homepage downplays is the membership: about $79 a month, billed separately, which covers visits and care coordination. Add them and the real cost is closer to $278 a month, still competitive but not the $199 your eye lands on first.

What you're buying for that membership is access to board-certified obesity-medicine clinicians and a flat medication price that doesn't escalate as you move up in dose. For a long titration, a fee that stays fixed while the dose climbs can work out cheaper than a "no membership" rival whose per-dose price keeps rising. Just price the two parts together, every time.

• Pros — flat $199 medication at any dose; shipping included; obesity-medicine physicians; honest pay-as-you-go structure.
• Cons — the $79/mo membership is separate, so the true cost is ~$278/mo, not the advertised $199.

Peak Wellness — best for flat per-dose pricing (watch the step-up)

Peak Wellness advertises a flat rate that doesn't change with your dose, which is a real advantage during titration. The number to watch is the timeline. The roughly $229 figure that draws you in is a first-month or annual-plan rate; from the second month onward the ongoing price steps up to about $349. That's still a fair flat price — it just isn't the introductory one, so budget for the standing cost rather than the teaser.

• Pros — one price regardless of dose; reasonable ongoing flat rate; compounded 503A.
• Cons — the low ~$229 is intro/annual-plan only and steps up to ~$349 after the first month.

Eden — best for no-membership flat pricing

Eden sits in the same honest middle of the pack: no membership fee, the same price whatever your dose, and a modest first-month discount. Expect roughly $249 to start and about $329 to $349 a month ongoing, depending on the plan you pick. Sources differ a few dollars on the exact ongoing rate, which is the norm in this category and exactly why the live figure is worth confirming before you commit.

• Pros — no separate membership; flat across doses; transparent first-month-then-ongoing structure.
• Cons — ongoing rate (~$329–$349) is higher than Curex; exact figure varies by source and plan.

Henry Meds — established name, oral or injection

Henry Meds is one of the most recognized names in compounded GLP-1s, and one of the few that offers tirzepatide as oral tablets as well as the standard injection. Oral tirzepatide runs about $349 a month and the injection about $449, with visits, supplies, and shipping bundled into that single price and no long-term contract — you're on a monthly plan you can cancel. It isn't the cheapest tirzepatide on this list, but the all-in simplicity and the needle-free oral option are the real draw.

One thing worth knowing if budget is the priority: Henry's semaglutide is noticeably cheaper than its tirzepatide — around $249 a month for the oral and $297 for the injection. Same provider, different molecule. If you're open to semaglutide rather than set on tirzepatide, that's a genuine saving to weigh against the modestly stronger results tirzepatide tends to show.

• Pros — offers both oral and injectable tirzepatide; visits, supplies and shipping bundled in; monthly plan, cancel anytime; recognized 503A provider.
• Cons — at $349–$449 it's mid-to-high here, not the cheapest tirzepatide; the cheaper Henry headlines you'll see are its semaglutide or low doses, not injectable tirzepatide.

Fridays — best for bundled coaching and support

Fridays prices itself as a program rather than a prescription. Compounded tirzepatide runs roughly $299 a month on a longer commitment, up toward $389 on shorter terms, and the price folds in coaching, a dietitian, and 24/7 messaging. There's also a microdose track around $198 a month for people who want to start gentler. If you value the wraparound support and would otherwise pay for coaching separately, the bundle reads better than the bare medication number suggests.

• Pros — coaching, dietitian and app access bundled in; lower per-month on a 12-month commitment; microdose option.
• Cons — entry price higher than the cheapest no-frills rivals; best rate needs a long commitment.

Remedy Meds — best for one flat price through titration

Remedy Meds keeps it refreshingly simple: about $399 a month, the same at every dose, with unlimited telehealth and shipping included. It isn't the cheapest entry point, but a price that holds steady while you titrate is worth real money — many programs quietly raise the monthly fee each time you step up, and a flat rate can overtake a lower-but-climbing competitor by your maintenance dose. Cash-pay only, like the rest of the compounded field.

• Pros — single flat price at all doses; no titration hikes; telehealth and shipping included.
• Cons — higher starting point than Curex, Mochi or Peak; cash-pay only, no insurance.

LillyDirect (Zepbound) — the FDA-approved brand reference

This is the one option here that is FDA-approved as a finished product, and it's far cheaper than it used to be. Eli Lilly sells Zepbound single-dose vials directly to self-pay patients through LillyDirect, and on the Self Pay Journey Program the price starts at $299 a month for 2.5mg, $399 for 5mg, and $449 for the 7.5mg-through-15mg doses. That brings the approved brand within touching distance of compounded pricing — without the regulatory question mark hanging over the cheaper options.

The fine print is a clock. To hold those prices you have to refill within 45 days of your last delivery; miss the window and the higher doses jump to roughly $499 to $699 a month. Standard vial pricing outside the program also runs higher — around $349, $499 and $599 by dose. For a woman who wants certainty over the lowest possible sticker, the small premium over compounded buys an approved product and a known supply chain.

• Pros — the only FDA-approved option here; direct from the manufacturer; now price-competitive with compounded at lower doses.
• Cons — strict 45-day refill rule to keep the rate, with steep late-refill penalties; higher doses cost more than the cheapest compounded programs.

Annual cost: what "cheapest" really saves you

Monthly numbers hide the stakes. The cheapest verified option, Gala at $179 a month on its yearly plan, works out to about $2,148 a year — if you stay the full twelve months. Curex at roughly $199 a month is about $2,388. Mochi all-in lands near $3,336, and the flat-rate brand-adjacent programs sit between those. LillyDirect's approved vials run roughly $3,588 a year at the lower doses on the on-time program.

Set any of those against the retail brand and the case for shopping carefully writes itself. Zepbound at a cash pharmacy without coupons runs about $1,086 a month — close to $13,032 a year. Choosing Gala or Curex over that retail price saves on the order of $10,000 in a single year. Even the pricier flat-rate compounded programs save you several thousand. The point isn't only the lowest tier; it's that nearly every option on this list beats the pharmacy counter by a wide margin.

Compounded vs brand-name: why the cheap price exists

Compounded tirzepatide is mixed by a pharmacy rather than manufactured and FDA-approved as a finished product. Through most of 2023 and 2024 this was everywhere, because tirzepatide sat on the FDA's drug shortage list — and a shortage opens a legal door for compounding pharmacies to fill the gap. That door is what made the low prices possible in the first place.

The shortage is over. The FDA declared it resolved in late 2024, then set wind-down dates: enforcement discretion for state-licensed 503A pharmacies ended on February 18, 2025, and for the larger 503B outsourcing facilities on March 19, 2025. The courts let those deadlines stand. Mass-market compounding of tirzepatide simply because it's cheaper is no longer the permitted norm.

What remains is narrow and individual. A 503A pharmacy may still compound tirzepatide for a specific patient when there's a documented clinical reason the approved version won't do — an allergy to an inactive ingredient, for instance — but not purely to save money. Several telehealth brands still offer compounded tirzepatide on that footing; the ground under those offers is evolving, which is the honest context behind every low price on this page.

• Compounded means pharmacy-mixed, not FDA-approved as a finished drug — the consistency and safety review differs from the brand.
• Any provider claiming to sell "FDA-approved compounded" tirzepatide is misstating it: compounded drugs are not FDA-approved by definition.
• Only the 503A individual-patient pathway remains after the FDA ended 503B discretion on March 19, 2025; broad shortage-era compounding is gone.
• Brand-name Zepbound and Mounjaro are the FDA-approved versions — and on self-pay vials, the brand is now far closer to compounded pricing than before.

How to choose a provider — and the red flags

A medication rate is not a monthly bill. Read every program for the same handful of things and the ranking can flip on you.

• Membership on top of medication — the dual-subscription trap. Ro Body and Mochi both charge a separate monthly fee; with Ro, a ~$145/mo membership plus brand medication pushes the real bill to roughly $445–$595. A low med price with a high membership can cost more than a flat-rate rival.
• Intro versus ongoing — a discounted first month is bait, not your standing cost. Peak Wellness and Eden both step up after month one. Price the month you'll pay all year.
• Dose-tier hikes — some programs raise the fee each time you titrate. A flat-at-all-doses price (Gala, ReadyRx, TrimRx, Mochi, Remedy, Peak) can beat a lower starter that climbs.
• Billing cycle — several providers bill every 28 days, which is thirteen charges a year, not twelve. That alone adds roughly eight percent to whatever monthly figure you were quoted.
• Non-refundable prepay — multi-month upfront plans (reported at Henry Meds; written into the terms at Gala, Joi and TrimRx) lock you into a compounded medication you haven't tried; understand the refund terms first.

One blunt rule cuts through most of it. If a compounded tirzepatide price drops below roughly $90 a month, treat it as a red flag rather than a deal — legitimate sourcing, clinician oversight and real pharmacy compounding cost more than that, and the headline-cheapest names are exactly where you should ask the most questions about how the product is made and who is prescribing it.

The cheapest option that actually fits a woman in perimenopause

The lowest price that suits your body beats the lowest price overall. Weight that climbs in your forties often tracks shifting hormones rather than willpower, and a GLP-1 is one tool among several, not the whole answer. Two of the programs above — Gala and Joi — put estradiol and progesterone on the same platform as the GLP-1, which matters if you would rather have one clinician looking at both. If you want the wider picture before you commit to a subscription, our guide to GLP-1 medications and menopause weight gain lays out where these drugs help and where they don't.

There's also a real case for the brand here that didn't exist a year ago. With LillyDirect self-pay vials starting near $299 a month, an FDA-approved option now sits within reach of the compounded price, minus the regulatory question mark. For some women that certainty is worth a small premium; for others the flat-rate compounded programs still win outright on cost. And if tirzepatide isn't settled for you, semaglutide runs cheaper — we track the cheapest verified semaglutide the same way.